- Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs CNBC
- Growth Portfolio Will Likely Drive Bristol Myers Squibb’s Q2 Forbes
- Bristol Myers Squibb results beat expectations as newer drugs deliver growth MarketWatch
- Bristol Myers Jumps As Cost Cuts Fuel Easy Earnings Beat Investor’s Business Daily
- Bristol-Myers Squibb Q2 Earnings Preview: Strong results on the back of legacy portfolio Seeking Alpha
#Bristol #Myers #Squibb #beats #earnings #estimates #raises #outlook #drugmaker #slashes #costs #CNBC,
#Bristol #Myers #Squibb #beats #earnings #estimates #raises #outlook #drugmaker #slashes #costs #CNBC